Autism Disorder In India – Present Scenario And Forecast -AcriIndia

1
Autism disorder is a developmental disorder that
is characterized by repetitive behavior,
communication challenges, and mote. Millions of
people suffer from this disorder every year,
which is only increasing year by year, and we
dont know where it will reach in the upcoming
years. Till date, no cure has been found to the
disorder. But, a number of treatments like
speech therapy and behavioural therapy are being
developed for the patients. Also, research and
development is being done to make further
treatments available in the market. Thus, there
will be an expansion of the autism disorder and
treatment market in the forthcoming years.
As per the Market Research Futures analysis, the
global autism disorder and treatment market is
expected to mark a CAGR of 4.37 during the
period of 2017 to 2023. However, a weak pipeline
for the drugs is expected to hinder the growth of
the market. In January 2019, a bill had been
advanced in Colorado to legalize the use of
marijuana for treating autism. During the same
time, a group of researchers in Japan also
conducted a clinical trial to make available a
drug as a nasal spray that can improve the
symptoms of autism spectrum disorder. In
addition, in Europe, the use of bumetanide had
been evaluated to treat children suffering from
autism.
2

• Some of the key players outlined in the Market
  Research Futures analysis include Pfizer Inc.,
  Allergan, Merck CO Inc., Eli Lilly and Company,
  Teva Pharmaceutical Industries Ltd., Novartis
  AG, Johnson Johnson Services, Inc.
  Bristol-Myers Squibb and Otsuka Holdings Co.,
  Ltd., Concern Pharma Private Limited, Coronis
  Partners Ltd., Heptares Therapeutics Limited,
  Curemark LLC, Intra-Cellular Therapies Inc., and
  Saniona AB.
• Segmentation
• The global autism disorder and treatment market
  has been segmented into Asperger Syndrome,
  Pervasive Developmental Disorder, and others,
  based on the type.
• Based in the treatment type, it has been
  segmented into applied behavioral analysis,
  hyperbaric oxygen therapy, chelation therapy,
  oxytocin therapy, and others.
• Based on the drug, it has been segmented into
  SSRIs, anti-convulsant, stimulants, anti-
  psychotic.
• Based on the region, it has been segmented into
  Americas, Europe, Asia Pacific, and the Middle
  East Africa. Americas has seen an upsurge in
  demand for autism screening tests
• due to the rising awareness, which may make it
  the largest regional autism disorder and
  treatment market globally in the future. Asia
  Pacific, on the other hand, has a significant
• proportion of autistic patients, but lesser
  awareness among the people for screening and
  treating the condition. But, with the rise in
  awareness, a favourable impact will be seen on
  the growth of the autism disorder and treatment
  market in the upcoming years. And,
• the Middle East and Africa regions, in the
  meantime, are likely to hold a small share of the
  market, but while exhibiting a steady growth.
• You can also lend a helping hand to your country
  to find treatments for many such incurable
  diseases by taking up clinical research as a
  serious profession. You can get enrolled at
  Avigna Clinical Research Institute to educate
  yourself with the professional clinical research
  courses
• in Bangalore that are taught by expert medical
  professors to give you complete knowledge about
  the field.